Page 12 - 03 Vantaggi
P. 12
ll'EMA e presenti sul mercato19
Authorization date Manufacturer/Company name
9 Sep 2014
Eli Lilly/Boehringer
28 Aug 2007 Ingelheim
Medice Arzneimittel Pütter
18 Sep 2014 Accord Healthcare
24 March 2014 Finox Biotech
28 Aug 2007 Sandoz
15 Sep 2008 CT Arzneimittel
28 Aug 2007 Hexal
6 Feb 2009 Hexal
18 Oct 2013 Apotex
10 Sep 2013 Hospira
- 10 -
Authorization date Manufacturer/Company name
9 Sep 2014
Eli Lilly/Boehringer
28 Aug 2007 Ingelheim
Medice Arzneimittel Pütter
18 Sep 2014 Accord Healthcare
24 March 2014 Finox Biotech
28 Aug 2007 Sandoz
15 Sep 2008 CT Arzneimittel
28 Aug 2007 Hexal
6 Feb 2009 Hexal
18 Oct 2013 Apotex
10 Sep 2013 Hospira
- 10 -
